Browse > Article
http://dx.doi.org/10.4014/kjmb.1311.11009

Anti-oxidative and Anti-cancer Activities by Cell Cycle Regulation of Salsola collina Extract  

Oh, You Na (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Jin, Soojung (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Park, Hyun-Jin (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Kwon, Hyun Ju (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Kim, Byung Woo (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Publication Information
Microbiology and Biotechnology Letters / v.42, no.1, 2014 , pp. 73-81 More about this Journal
Abstract
Salsola collina, also known as Russian thistle, is widely distributed in and around waste facilities, roadsides, and drought and semi-drought areas, and is used as a traditional folk remedy in Chinese medicine for the treatment of hypertension. In this study, we have evaluated the anti-oxidative and anti-cancer activities of the ethanol extract of S. collina Pall. (EESC), and the molecular mechanisms of its anti-cancer effects on human colon carcinoma HT29 cells. EESC exhibited anti-oxidative activity through DPPH radical scavenging capacity and showed cytotoxic activity in a dose-dependent manner in HT29 cells. After EESC treatment, HT29 cells altered their morphology, becoming smaller and irregular in shape. EESC also induced cell accumulation in the G2/M phase in a dose-dependent manner, accompanied by a decrease of cell population in the G1 phase. The G2/M arrest by EESC was associated with the increased expression of cyclin-dependent kinase (CDK) inhibitor p21 and Wee1 kinase, which phosphorylates, or inactivates, Cdc2. EESC treatment induced the phosphorylation of Cdc2 and Cdc25C, and inhibited cyclin A and Cdc25C protein expression. In addition, S arrest was induced by the highest concentration of EESC treatment, associated with a decrease of cyclin A and Cdk2 expression. These findings suggest that EESC may possess remarkable anti-oxidative activity and exert an anti-cancer effect in HT29 cells by cell cycle regulation.
Keywords
Anti-cancer activity; anti-oxidative activity; Cdc25C; G2/M arrest; p21; Salsola collina;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Cha MR, Yoon MY, Kim JY, Hwang JH, Park HR. 2006. The cytotoxic effect of the Gleditsiae semen extracts oh human colon carcinoma cells. J. Korean Soc. Appl. Biol. Chem. 49: 248-253.
2 Chang CH, Yu FY, Wu TS, Wang LT, Liu BH. 2011. Mycotoxin citrinin induced cell cycle G2/M arrest and numerical chromosomal aberration associated with disruption of microtubule formation in human cells. Toxicol. Sci. 119: 84-92.   DOI   ScienceOn
3 Donzelli M, Draetta GF. 2003. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Reports 4: 671-677.   DOI   ScienceOn
4 Dorai T, Aggarwal BB. 2004. Role of chemopreventive agents in cancer therapy. Cancer Lett. 215: 120-140.
5 Dulic V, Stein GH, Far DF, Reed SI. 1998. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 18: 546-557.   DOI
6 Elledge SJ, Harper JW. 1994. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6: 847-852.   DOI   ScienceOn
7 Aktas H, Cai H, Cooper GM. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17: 3850-3857.   DOI
8 Albert H, Santos S, Battaglia E, Brito M, Monteiro C, Bagrel D. 2011. Differential expression of CDC25 phosphatases splice variants in human breast cancer cells. Clin. Chem. Lab. Med. 49: 1707-1714.
9 Sherr CJ. 1996. Cancer cell cycles. Science 274: 1672-1677.   DOI   ScienceOn
10 Park JY, Kang KS, Sohn YK. 2010. Molecular mechanism of the G2/M arrest in breast cancer cell lines (T47D and MDAMB231) induced by Genistein. J. Breast Cancer 13: 382-391.   DOI
11 Reiter RJ. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9: 526-533.   DOI
12 Tchou WW, Rom WN, Tchou-Wong KM. 1996. Novel form of p21WAF1/CIP1/SDI1 protein in phorbol ester induced G2/M arrest. J. Biol. Chem. 271: 29556-29560.   DOI   ScienceOn
13 Seo GS. 2011. The role of NF-kB in colon cancer. Korean J. Gastroenterol. 57: 3-7.   DOI
14 Shi J, Gong J, Liu J, Wu X, Zhang Y. 2009. Antioxidant capacity of extract from edible flowers of Prunus mume in China and its active components. LWT-Food Sci. Technol. 42: 477-482.   DOI   ScienceOn
15 Sun H, Hou H, Lu P, Zhang L, Zhao F, Ge C, et al. 2012. Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis. PLoS One 7: e36808.   DOI
16 Yao Y, Zhang YW, Sun LG, Liu B, Bao YL, Lin H, et al. 2012. Juglanthraquinone C, a novel natural compound derived from Juglans mandshurica Maxim, induces S phase arrest and apoptosis in HepG2 cells. Apoptosis 17: 832-841.   DOI
17 Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, et al. 1995. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/marcrophage differentiation. Cancer Res. 55: 668-674.
18 Lees E. 1995. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7: 773-780.   DOI   ScienceOn
19 Katsube T, Tabata H, Ohta Y, Yamasaki Y, Anuurad E, Shiwaku K, et al. 2004. Screening for antioxidant activity in edible plant products: comparison of low-density lipoprotein oxidation assay, DPPH radical scavenging assay, and Folin-Ciocalteu assay. J. Agric. Food. Chem. 52: 2391-2396.   DOI   ScienceOn
20 Khalil ML. 2006. Biological activity of bee propolis in health and disease. Asian Pac. J. Cancer Prev. 7: 22-31.
21 King RW, Jackson PK, Kirschner MW. 1994. Mitosis in transition. Cell 79: 563-571.   DOI   ScienceOn
22 Lee JH, Kim YC, Woo HJ. 1999. Study on the anti-cancer effect of Acanthopanax sessiliflorus. J. Korean Oriental Med. 20: 464-475.
23 McGowan CH, Russell P. 1993. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr 15. EMBO J. 12: 75-85.
24 Li BZ, Chen ZL, Shi SS, Feng XL, Tan XG, Zhou F, et al. 2013. Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery. Chin. J. Cancer 32: 403-409.
25 Li Y, Jenkins CW, Nichols MA, Xiong Y. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9: 2261-2268.
26 Malumbres M, Barbacid M. 2009. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9: 153-166.   DOI   ScienceOn
27 Meijer L. 1996. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6: 393-397.   DOI   ScienceOn
28 Morgan DO. 1995. Principles of CDK regulation. Nature 374: 131-134.   DOI   ScienceOn
29 Nasmyth K. 1996. Viewpoint: putting the cell cycle in order. Science 274: 1643-1645.   DOI   ScienceOn
30 Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70: 461-477.   DOI   ScienceOn
31 Hartwell LH, Kastan MB. 1994. Cell cycle control and cancer. Science 266: 1821-1828.   DOI
32 Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, et al. 2005. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell bissemination. Thromb. Haemost. 93: 964-975.
33 Green JR. 2004. Bisphosphonates: preclinical review. Oncologist 4: 3-13.
34 Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-65.   DOI   ScienceOn
35 Hartwell LH, Weinert TA. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-633.   DOI
36 Jin P, Gu Y, Morgan DO. 1996. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134: 963-970.   DOI   ScienceOn
37 Hassan BA, Yusoff ZB. 2010. Negative Impact of Chemotherapy on Breast Cancer Patients QOL - Utility of Antiemetic Treatment Guidelines and the Role of Race. Asian Pac. J. Cancer Prev. 11: 1523-1527.
38 Jermal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J. Clin. 61: 69-90.   DOI
39 Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB. 1994. Induction of differentiation in human promyelocytic HL- 60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406.
40 Jin YS, Du JL, Yang Y, Jin L, Song Y, Zhang W, et al. 2011. Chemical and biologically active constituents of Salsola collina. Chem. Nat. Compd. 47: 257-260.   DOI
41 Jo HJ, Song JD, Kim KM, Cho YH, Kim KH, Park YC. 2008. Diallyl disulfide induces reversible G2/M phase arrest on a p53-independent mechanism in human colon cancer HCT- 116 cells. Oncol. Rep. 19: 275-280.
42 Booher RN, Holman PS, Fattaey A. 1997. Human Myt1 is a cell cycle regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem. 272: 22300-22306.   DOI
43 An Y. 1999. Prospective and retrospective studies on risk factors of four most common cancers in Korean males: stomach, live, lung and colorectum. Seoul, Ministry of Health & Welfare.
44 Aranha O, Wood DP Jr, Sarkar FH. 2000. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin. Cancer Res. 6: 891-900.
45 Arellano M, Moreno S. 1997. Regulation of CDK/cyclin complexes during the cell cycle. Int. J. Biochem. Cell Biol. 29: 559-573.   DOI   ScienceOn
46 Byar KL, Berger AM, Bakken SL, Cetak MA. 2006. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol. Nurs. Forum 33: E18-26.   DOI   ScienceOn